148 related articles for article (PubMed ID: 35568411)
21. Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients.
Breen DJ; Bryant TJ; Abbas A; Shepherd B; McGill N; Anderson JA; Lockyer RC; Hayes MC; George SL
BJU Int; 2013 Oct; 112(6):758-65. PubMed ID: 23581293
[TBL] [Abstract][Full Text] [Related]
22. Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4 cm in diameter: a prospective observational study.
Gobara H; Hiraki T; Iguchi T; Matsui Y; Sakurai J; Uka M; Tomita K; Komaki T; Kobayasi Y; Araki M; Watanabe T; Kanazawa S
Int J Clin Oncol; 2021 Mar; 26(3):562-568. PubMed ID: 33174078
[TBL] [Abstract][Full Text] [Related]
23. Successful conservative management of colorenal fistula after percutaneous cryoablation of renal-cell carcinoma.
Vanderbrink BA; Rastinehad A; Caplin D; Ost MC; Lobko I; Lee BR
J Endourol; 2007 Jul; 21(7):726-9. PubMed ID: 17705759
[TBL] [Abstract][Full Text] [Related]
24. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous treatment of renal tumours.
Uppot RN; Wah TM; Mueller PR
J Med Imaging Radiat Oncol; 2023 Dec; 67(8):853-861. PubMed ID: 37417722
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of percutaneous core biopsy before cryoablation for small-sized renal cell carcinoma.
Ushijima Y; Nishie A; Fujita N; Kubo Y; Ishimatsu K; Ishigami K
Diagn Interv Radiol; 2023 Nov; 29(6):800-804. PubMed ID: 36994482
[TBL] [Abstract][Full Text] [Related]
27. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses.
Hinshaw JL; Shadid AM; Nakada SY; Hedican SP; Winter TC; Lee FT
AJR Am J Roentgenol; 2008 Oct; 191(4):1159-68. PubMed ID: 18806159
[TBL] [Abstract][Full Text] [Related]
28. Value of percutaneous needle biopsy of small renal tumors in patients referred for cryoablation.
Iguchi T; Hiraki T; Gobara H; Fujiwara H; Sakurai J; Matsui Y; Araki M; Nasu Y; Kanazawa S
Minim Invasive Ther Allied Technol; 2017 Apr; 26(2):86-91. PubMed ID: 27750475
[TBL] [Abstract][Full Text] [Related]
29. [A Case of Recurrent Renal Cancer in the Autografted Kidney, Treated with Percutaneous Cryoablation].
Tomiyama E; Fukuhara S; Ujike T; Nagahara A; Uemura M; Kiuchi H; Imamura R; Miyagawa Y; Nin M; Nonomura N
Hinyokika Kiyo; 2016 Oct; 62(10):539-543. PubMed ID: 27919129
[TBL] [Abstract][Full Text] [Related]
30. Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience.
Tanagho YS; Bhayani SB; Kim EH; Figenshau RS
J Endourol; 2013 Dec; 27(12):1477-86. PubMed ID: 24283518
[TBL] [Abstract][Full Text] [Related]
31. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease.
Wehrenberg-Klee E; Clark TW; Malkowicz SB; Soulen MC; Wein AJ; Mondschein JI; Van Arsdalen K; Guzzo TJ; Stavropoulos SW
J Vasc Interv Radiol; 2012 Jan; 23(1):41-5. PubMed ID: 22019179
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous MR-guided cryoablation for malignancies, with a focus on renal cell carcinoma.
Mogami T; Harada J; Kishimoto K; Sumida S
Int J Clin Oncol; 2007 Apr; 12(2):79-84. PubMed ID: 17443274
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience.
Atwell TD; Farrell MA; Callstrom MR; Charboneau JW; Leibovich BC; Patterson DE; Chow GK; Blute ML
Radiology; 2007 Apr; 243(1):276-83. PubMed ID: 17329689
[TBL] [Abstract][Full Text] [Related]
34. Contrast enhancement early after renal malignancy cryoablation: imaging findings associated with benignity.
Grand T; Delavaud C; Dariane C; Ramtohul T; Guinebert S; Hélénon O; Mejean A; Timsit MO; Correas JM; Bodard S
Eur Radiol; 2023 Dec; 33(12):8703-8714. PubMed ID: 37405502
[TBL] [Abstract][Full Text] [Related]
35. Incidence of Post-ablation Syndrome Following Image-Guided Percutaneous Cryoablation of Renal Cell Carcinoma: A Prospective Study.
Zhong J; Bambrook J; Bhambra B; Smith J; Cartledge J; Ralph C; Vasudev N; Whiteley S; Wah T
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):270-276. PubMed ID: 29185017
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?
Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E
J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831
[TBL] [Abstract][Full Text] [Related]
37. Evolutionary magnetic resonance appearance of renal cell carcinoma after percutaneous cryoablation.
Lee HJ; Chung HJ; Wang HK; Shen SH; Chang YH; Chen CK; Chou HP; Chiou YY
Br J Radiol; 2016 Sep; 89(1065):20160151. PubMed ID: 27401340
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study.
Georgiades CS; Rodriguez R
Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1494-9. PubMed ID: 24385225
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
